Nature Publishing Group

SHERPA: Yellow

People

  1. Sadelain
    Sadelain
  2. Wang
    Wang
  3. Park
    Park
  4. Stefanski
    Stefanski
  5. Curran
    Curran
  6. Qu
    Qu
  7. Bernal
    Bernal
  8. Du
    Du
  9. Heller
    Heller
  10. O'Cearbhaill
    O'Cearbhaill

Groups

  1. Department of Medicine (67)
  2. Hematologic Malignancies, Division of (67)
  3. Center for Hematologic Malignancies (57)
  4. GSK Faculty (56)
  5. Hematologic Malignancies Research (55)
  6. Sloan Kettering Institute Faculty (54)
  7. Molecular Pharmacology and Chemistry Program Faculty (53)
  8. Adult Leukemia (25)
  9. Sloan Kettering Institute Postdocs (13)
  10. Pediatrics, Department of (12)
Search Within
  1. "Isabelle Riviere"
Formats
  1. Meeting Abstract (35)
  2. Journal Article (31)
  3. Research Letter (1)
Groups
  1. Department of Medicine (67)
  2. Hematologic Malignancies, Division of (67)
  3. Center for Hematologic Malignancies (57)
  4. GSK Faculty (56)
  5. Hematologic Malignancies Research (55)
  6. Sloan Kettering Institute Faculty (54)

More Groups

People
  1. Isabelle Riviere (67)
  2. Michel Sadelain (53)
  3. Xiuyan Wang (27)
  4. Renier Brentjens (22)
  5. Jae Park (13)
  6. Jolanta Stefanski (12)

More People

Years
  1. 2023 (3)
  2. 2022 (4)
  3. 2021 (4)
  4. 2020 (2)
  5. 2019 (4)
  6. 2018 (7)

More Years

Publications
  1. Molecular Therapy (42)
  2. Nature Biotechnology (6)
  3. Nature Medicine (5)
  4. Molecular Therapy - Methods & Clinical Development (3)
  5. Bone Marrow Transplantation (2)
  6. Gene Therapy (2)

More Publications

Results (67)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing the relationship between cellular kinetics and response to support dosing recommendations for Cd19-targeted 19(T2)28z1xx cell therapy
    Meeting Abstract

    Li, J.; Singh, R.; Dey, A.; Sellner, L.; Liu, R.; Dash, A.; Park, J.; Palomba, M.; Mansilla-Soto, J.; Senechal, B.; more...
    Clinical Pharmacology & Therapeutics (2023)

    Fulltext@MSK | Save
  • CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: Phase 2 trial interim results
    Journal Article

    Park, J. H.; Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G.; Dahi, P.; Lin, R. J.; Scordo, M.; Perales, M. A.; more...
    Nature Medicine (2023)

    Fulltext@MSK | Save
  • Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials
    Journal Article

    Cornetta, K.; Yao, J.; House, K.; Duffy, L.; Adusumilli, P. S.; Beyer, R.; Booth, C.; Brenner, M.; Curran, K.; Grilley, B.; more...
    Molecular Therapy (2023)

    Fulltext@MSK | Save
  • Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells
    Journal Article

    van der Stegen, S. J. C.; Lindenbergh, P. L.; Petrovic, R. M.; Xie, H.; Diop, M. P.; Alexeeva, V.; Shi, Y.; Mansilla-Soto, J.; Hamieh, M.; Eyquem, J.; more...
    Nature Biomedical Engineering (2022)

    Fulltext@MSK | Save
  • Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy
    Journal Article

    Smith, M.; Dai, A.; Ghilardi, G.; Amelsberg, K. V.; Devlin, S. M.; Pajarillo, R.; Slingerland, J. B.; Beghi, S.; Herrera, P. S.; Giardina, P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • HLA-independent T cell receptors for targeting tumors with low antigen density
    Journal Article

    Mansilla-Soto, J.; Eyquem, J.; Haubner, S.; Hamieh, M.; Feucht, J.; Paillon, N.; Zucchetti, A. E.; Li, Z.; Sjöstrand, M.; Lindenbergh, P. L.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: A phase 1 trial
    Journal Article

    Boulad, F.; Maggio, A.; Wang, X.; Moi, P.; Acuto, S.; Kogel, F.; Takpradit, C.; Prockop, S.; Mansilla-Soto, J.; Cabriolu, A.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia
    Research Letter

    Perica, K.; Flynn, J.; Curran, K. J.; Rivere, I.; Wang, X.; Senechal, B.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; more...
    Leukemia (2021)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Decreased neuroprotective analytes on day of infusion of chimeric antigen receptor (CAR) T cells are associated with neurotoxicity
    Meeting Abstract

    Lakkaraja, M.; Hosszu, K.; McAvoy, D.; Mauguen, A.; Purdon, T. J.; Khakoo, Y.; Santomasso, B. D.; Riviere, I.; Sadelain, M.; Curran, K. J.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save

    • Nature Publishing Group – authorized name for: